Vanta Bioscience Ltd has received an order of Rs. 57 Lakh from a renowned Singapore Company to carry out GLP Studies which includes Bacterial Reverse Mutation assay, oral toxicity study and in vitro tests and other studies.
The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the Company for the project will be 26 weeks from receipt of requisite test items and/or such extended period as mutually agreed.
This major order has been added to the existing impressive order book of the Company comprising of multiple studies received by the Company which aggregates to over Rs. 10 Crores.
After successfully getting the Resolution proceedings settled, and regaining absolute control of the company, the promoters and directors have refocused their energies to revive the Company financially and in all other aspects. With diligent efforts and unwavering support of the VantaBioscience family, its employees and all its stakeholders, the company is positive of increasing its market share in the industry thereby increasing the turnover and profits of the Company in the coming financial years. With its relentless efforts, the Company has regained the confidence of its long term clients from India and abroad and is working towards adding back existing and new marquee clients in its order book.
The Company is targeting international clients, especially from Japan and Europe within the next few months. The Company has already cleared several audits of certain international companies and is optimistic that these will help the Company in generating revenue in the coming financial years. This is for the information of all the stakeholders.